{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T11:19:27Z","timestamp":1764587967721,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T00:00:00Z","timestamp":1538611200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1C1B5076797"],"award-info":[{"award-number":["2017R1C1B5076797"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1245\/s10434-018-6828-4","type":"journal-article","created":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T12:37:39Z","timestamp":1538656659000},"page":"3898-3905","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["C-Reactive Protein Level Predicts Survival Outcomes in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation Therapy"],"prefix":"10.1245","volume":"25","author":[{"given":"Woo Ram","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon Dae","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung Soh","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,4]]},"reference":[{"issue":"6917","key":"6828_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860\u20137.","journal-title":"Nature"},{"issue":"8","key":"6828_CR2","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nri1415","volume":"4","author":"J Vakkila","year":"2004","unstructured":"Vakkila J, Lotze MT. Inflammation and necrosis promote tumour growth. Nat Rev Immunol. 2004;4(8):641\u20138.","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"6828_CR3","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/sj.bjc.6603150","volume":"94","author":"AB Crumley","year":"2006","unstructured":"Crumley AB, McMillan DC, McKernan M, Going JJ, Shearer CJ, Stuart RC. An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer. 2006;94(11):1568\u201371.","journal-title":"Br J Cancer"},{"issue":"9","key":"6828_CR4","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1136\/jech.2006.051292","volume":"61","author":"K Heikkila","year":"2007","unstructured":"Heikkila K, Ebrahim S, Lawlor DA. A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health. 2007;61(9):824\u201333.","journal-title":"J Epidemiol Community Health"},{"key":"6828_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1471-2407-9-155","volume":"9","author":"DK Kim","year":"2009","unstructured":"Kim DK, Oh SY, Kwon HC, et al. Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer. BMC Cancer. 2009;9:155.","journal-title":"BMC Cancer"},{"issue":"9","key":"6828_CR6","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/sj.bjc.6604027","volume":"97","author":"EF Leitch","year":"2007","unstructured":"Leitch EF, Chakrabarti M, Crozier JE, et al. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer. 2007;97(9):1266\u201370.","journal-title":"Br J Cancer"},{"issue":"8","key":"6828_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/j.1478-3231.2007.01550.x","volume":"27","author":"S Nagaoka","year":"2007","unstructured":"Nagaoka S, Yoshida T, Akiyoshi J, et al. Serum C-reactive protein levels predict survival in hepatocellular carcinoma. Liver Int. 2007;27(8):1091\u20137.","journal-title":"Liver Int"},{"issue":"14","key":"6828_CR8","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/jnci\/djr216","volume":"103","author":"SR Pine","year":"2011","unstructured":"Pine SR, Mechanic LE, Enewold L, et al. Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer. J Natl Cancer Inst. 2011;103(14):1112\u201322.","journal-title":"J Natl Cancer Inst"},{"key":"6828_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0065-2776(08)60379-X","volume":"34","author":"MB Pepys","year":"1983","unstructured":"Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol. 1983;34:141\u2013212.","journal-title":"Adv Immunol"},{"issue":"4","key":"6828_CR10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0002-9610(98)00204-9","volume":"176","author":"T Nozoe","year":"1998","unstructured":"Nozoe T, Matsumata T, Kitamura M, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg. 1998;176(4):335\u20138.","journal-title":"Am J Surg"},{"issue":"4","key":"6828_CR11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/sj.bjc.6602419","volume":"92","author":"K Canna","year":"2005","unstructured":"Canna K, McArdle PA, McMillan DC, et al. The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer. 2005;92(4):651\u20134.","journal-title":"Br J Cancer"},{"issue":"3","key":"6828_CR12","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s12032-013-0656-y","volume":"30","author":"J Dreanic","year":"2013","unstructured":"Dreanic J, Maillet M, Dhooge M, et al. Prognostic value of the Glasgow Prognostic Score in metastatic colorectal cancer in the era of anti-EGFR therapies. Med Oncol. 2013;30(3):656.","journal-title":"Med Oncol"},{"issue":"11","key":"6828_CR13","first-page":"5051","volume":"33","author":"M Fukuchi","year":"2013","unstructured":"Fukuchi M, Kuwabara K, Tsuji Y, et al. C-reactive protein is a negative independent factor in patients with stage IV colorectal cancer undergoing oxaliplatin-based chemotherapy. Anticancer Res. 2013;33(11):5051\u20135.","journal-title":"Anticancer Res"},{"issue":"6","key":"6828_CR14","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.3892\/etm.2013.1350","volume":"6","author":"M Lin","year":"2013","unstructured":"Lin M, Huang J, Zhu J, Shen H. Elevated pre-treatment levels of high sensitivity C-reactive protein as a potential prognosticator in patients with colorectal cancer. Exp Ther Med. 2013;6(6):1369\u201374.","journal-title":"Exp Ther Med"},{"issue":"11","key":"6828_CR15","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s11605-009-1034-0","volume":"13","author":"CS Roxburgh","year":"2009","unstructured":"Roxburgh CS, Salmond JM, Horgan PG, Oien KA, McMillan DC. The relationship between the local and systemic inflammatory responses and survival in patients undergoing curative surgery for colon and rectal cancers. J Gastrointest Surg. 2009;13(11):2011\u20138 (discussion 2018\u20139).","journal-title":"J Gastrointest Surg"},{"issue":"11","key":"6828_CR16","first-page":"5065","volume":"33","author":"Y Toiyama","year":"2013","unstructured":"Toiyama Y, Inoue Y, Saigusa S, et al. C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery. Anticancer Res. 2013;33(11):5065\u201374.","journal-title":"Anticancer Res"},{"issue":"6","key":"6828_CR17","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.3892\/ol.2013.1308","volume":"5","author":"Y Toiyama","year":"2013","unstructured":"Toiyama Y, Fujikawa H, Koike Y, et al. Evaluation of preoperative C-reactive protein aids in predicting poor survival in patients with curative colorectal cancer with poor lymph node assessment. Oncol Lett. 2013;5(6):1881\u20138.","journal-title":"Oncol Lett"},{"issue":"11","key":"6828_CR18","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C","volume":"73","author":"AM Mandard","year":"1994","unstructured":"Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer. 1994;73(11):2680\u20136.","journal-title":"Cancer"},{"issue":"11","key":"6828_CR19","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1001\/archsurg.143.11.1091","volume":"143","author":"BS Min","year":"2008","unstructured":"Min BS, Choi YJ, Pyo HR, et al. Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer. Arch Surg. 2008;143(11):1091\u20137 (discussion 1097).","journal-title":"Arch Surg"},{"issue":"10","key":"6828_CR20","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1056\/NEJM199509073331001","volume":"333","author":"E Giovannucci","year":"1995","unstructured":"Giovannucci E, Egan KM, Hunter DJ, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med. 1995;333(10):609\u201314.","journal-title":"N Engl J Med"},{"key":"6828_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2407-3-28","volume":"3","author":"A Gonzalez-Perez","year":"2003","unstructured":"Gonzalez-Perez A, Garcia Rodriguez LA, Lopez-Ridaura R. Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. BMC Cancer. 2003;3:28.","journal-title":"BMC Cancer"},{"issue":"16","key":"6828_CR22","first-page":"3491","volume":"58","author":"Y Naito","year":"1998","unstructured":"Naito Y, Saito K, Shiiba K, et al. CD8\u2009+\u2009T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 1998;58(16):3491\u20134.","journal-title":"Cancer Res"},{"issue":"2","key":"6828_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s002620050603","volume":"49","author":"DA Arenberg","year":"2000","unstructured":"Arenberg DA, Keane MP, DiGiovine B, et al. Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines. Cancer Immunol Immunother. 2000;49(2):63\u201370.","journal-title":"Cancer Immunol Immunother"},{"issue":"7","key":"6828_CR24","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/bjs.4333","volume":"90","author":"HP Redmond","year":"2003","unstructured":"Redmond HP. Systemic inflammatory response predicts survival following curative resection of colorectal cancer (Br J Surg 2003;90:215\u20139). Br J Surg. 2003;90(7):889 (author reply 889).","journal-title":"Br J Surg"},{"issue":"4","key":"6828_CR25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10350-007-9133-z","volume":"51","author":"YC Shiu","year":"2008","unstructured":"Shiu YC, Lin JK, Huang CJ, et al. Is C-reactive protein a prognostic factor of colorectal cancer? Dis Colon Rectum. 2008;51(4):443\u20139.","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"6828_CR26","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0360-3016(00)01426-7","volume":"49","author":"M Cengiz","year":"2001","unstructured":"Cengiz M, Akbulut S, Atahan IL, Grigsby PW. Acute phase response during radiotherapy. Int J Radiat Oncol Biol Phys. 2001;49(4):1093\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"6828_CR27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.semcancer.2004.08.010","volume":"15","author":"MH Barcellos-Hoff","year":"2005","unstructured":"Barcellos-Hoff MH. Integrative radiation carcinogenesis: interactions between cell and tissue responses to DNA damage. Semin Cancer Biol. 2005;15(2):138\u201348.","journal-title":"Semin Cancer Biol"},{"issue":"29","key":"6828_CR28","doi-asserted-by":"publisher","first-page":"27537","DOI":"10.18632\/oncotarget.4826","volume":"6","author":"M Timaner","year":"2015","unstructured":"Timaner M, Bril R, Kaidar-Person O, et al. Dequalinium blocks macrophage-induced metastasis following local radiation. Oncotarget. 2015;6(29):27537\u201354.","journal-title":"Oncotarget"},{"issue":"6","key":"6828_CR29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1684\/bdc.2011.1372","volume":"98","author":"C Ruegg","year":"2011","unstructured":"Ruegg C, Monnier Y, Kuonen F, Imaizumi N. Radiation-induced modifications of the tumor microenvironment promote metastasis. Bull Cancer. 2011;98(6):47\u201357.","journal-title":"Bull Cancer"},{"issue":"7","key":"6828_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nrc3958","volume":"15","author":"HE Barker","year":"2015","unstructured":"Barker HE, Paget JT, Khan AA, Harrington KJ. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer. 2015;15(7):409\u201325.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"6828_CR31","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1245\/s10434-016-5684-3","volume":"24","author":"SB Dreyer","year":"2017","unstructured":"Dreyer SB, Powell AG, McSorley ST, et al. The pretreatment systemic inflammatory response is an important determinant of poor pathologic response for patients undergoing neoadjuvant therapy for rectal cancer. Ann Surg Oncol. 2017;24(5):1295\u2013303.","journal-title":"Ann Surg Oncol"},{"issue":"14_Suppl","key":"6828_CR32","doi-asserted-by":"publisher","first-page":"3693-3","DOI":"10.1200\/jco.2004.22.14_suppl.3693","volume":"22","author":"G Klautke","year":"2004","unstructured":"Klautke G, Foitzik T, Ludwig K, Klar EJM, Fietkau R. Intensified neoadjuvant chemoradiotherapy (CRT) with capecitabine and irinotecan in patients with locally advanced rectal cancer (LARC): A phase I\/II study. J Clin Oncol. 2004;22(14_Suppl):3693-3.","journal-title":"J Clin Oncol"},{"issue":"10","key":"6828_CR33","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1200\/JCO.2009.25.8376","volume":"28","author":"JP Gerard","year":"2010","unstructured":"Gerard JP, Azria D, Gourgou-Bourgade S, et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12\/0405-Prodige 2. J Clin Oncol. 2010;28(10):1638\u201344.","journal-title":"J Clin Oncol"},{"issue":"8","key":"6828_CR34","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S1470-2045(15)00159-X","volume":"16","author":"C R\u00f6del","year":"2015","unstructured":"R\u00f6del C, Graeven U, Fietkau R, et al. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO\/ARO\/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2015;16(8):979\u201389.","journal-title":"Lancet Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-018-6828-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6828-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6828-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T19:04:25Z","timestamp":1570129465000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-018-6828-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,4]]},"references-count":34,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["6828"],"URL":"https:\/\/doi.org\/10.1245\/s10434-018-6828-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2018,10,4]]},"assertion":[{"value":"14 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}